44 results
8-K
EX-99.6
KA
Kineta Inc
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to product pricing … on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other
8-K
EX-99.5
j8wkat 89pv6z
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
424B3
7w74v1nl
10 Nov 22
Prospectus supplement
4:21pm